Exponent, Inc. (NASDAQ:EXPO – Get Free Report) CEO Catherine Corrigan sold 1,663 shares of the stock in a transaction on Thursday, January 15th. The stock was sold at an average price of $72.52, for a total value of $120,600.76. Following the completion of the transaction, the chief executive officer owned 92,723 shares in the company, valued at approximately $6,724,271.96. This represents a 1.76% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.
Catherine Corrigan also recently made the following trade(s):
- On Monday, December 15th, Catherine Corrigan sold 3,225 shares of Exponent stock. The shares were sold at an average price of $70.74, for a total transaction of $228,136.50.
- On Monday, November 17th, Catherine Corrigan sold 4,900 shares of Exponent stock. The stock was sold at an average price of $70.39, for a total value of $344,911.00.
Exponent Price Performance
Shares of EXPO stock traded down $1.19 during trading hours on Tuesday, reaching $73.39. The company had a trading volume of 227,825 shares, compared to its average volume of 280,001. The company has a market cap of $3.66 billion, a price-to-earnings ratio of 35.80 and a beta of 0.81. Exponent, Inc. has a 12 month low of $63.81 and a 12 month high of $97.57. The business has a fifty day simple moving average of $72.20 and a 200-day simple moving average of $70.99.
Exponent Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Friday, December 19th. Investors of record on Friday, December 5th were issued a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a yield of 1.6%. The ex-dividend date was Friday, December 5th. Exponent’s dividend payout ratio (DPR) is 58.54%.
Exponent announced that its Board of Directors has approved a stock repurchase program on Thursday, October 30th that authorizes the company to repurchase $100.00 million in outstanding shares. This repurchase authorization authorizes the business services provider to reacquire up to 3% of its shares through open market purchases. Shares repurchase programs are typically an indication that the company’s board believes its stock is undervalued.
Analyst Upgrades and Downgrades
Several equities analysts have weighed in on EXPO shares. UBS Group reissued a “neutral” rating and set a $81.00 price objective (up from $76.00) on shares of Exponent in a report on Monday, December 15th. William Blair raised Exponent from a “market perform” rating to an “outperform” rating in a report on Monday, November 17th. Finally, Weiss Ratings reiterated a “hold (c-)” rating on shares of Exponent in a research report on Wednesday, October 8th. One research analyst has rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat, the company has an average rating of “Hold” and an average target price of $81.00.
Get Our Latest Analysis on EXPO
Institutional Trading of Exponent
Institutional investors have recently made changes to their positions in the stock. Hantz Financial Services Inc. increased its stake in shares of Exponent by 97.0% in the third quarter. Hantz Financial Services Inc. now owns 396 shares of the business services provider’s stock worth $28,000 after buying an additional 195 shares during the period. Aster Capital Management DIFC Ltd bought a new stake in Exponent in the 3rd quarter worth $33,000. BNP PARIBAS ASSET MANAGEMENT Holding S.A. bought a new stake in Exponent in the 2nd quarter worth $34,000. Winnow Wealth LLC purchased a new position in shares of Exponent in the third quarter valued at about $34,000. Finally, Pilgrim Partners Asia Pte Ltd bought a new position in shares of Exponent during the third quarter valued at about $38,000. Hedge funds and other institutional investors own 92.37% of the company’s stock.
Exponent Company Profile
Exponent, Inc (NASDAQ: EXPO) is an engineering and scientific consulting firm that offers multidisciplinary analysis and advisory services to clients across a range of industries. The company’s expertise spans mechanical, materials and corrosion engineering, civil and structural engineering, electrical engineering, industrial hygiene, toxicology and health sciences, and failure analysis. Exponent provides support for product design, performance evaluation, litigation consulting, and regulatory compliance, helping manufacturers, insurers, law firms and government agencies address complex technical challenges.
Founded in 1967 in Menlo Park, California, Exponent has grown from a small failure-analysis laboratory into a global consulting practice.
Featured Stories
- Five stocks we like better than Exponent
- Is Elon Preparing for a Silver Shock?
- Wall Street Alert: Buy AES
- Do not delete, read immediately
- Trump’s AI Secret: 100X Faster Than Nvidia
- The $100 Trillion AI Story No One Is Telling You
Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.
